4-(3-Chloropropyl)morpholine CAS 7357-67-7 Gefitinib Maʻemaʻe Kūwaena >98.0% (GC)
ʻO Ruifu Chemical ka mea hana nui o 4-(3-Chloropropyl)morpholine (CAS: 7357-67-7) me ke kūlana kiʻekiʻe, waena o Gefitinib (CAS: 184475-35-2).Hiki iā Ruifu Chemical ke hāʻawi aku i ka honua holoʻokoʻa, ke kumukūʻai hoʻokūkū, ka lawelawe maikaʻi loa, ka liʻiliʻi a me ka nui nui i loaʻa.Kūʻai 4-(3-Chloropropyl)morpholine,Please contact: alvin@ruifuchem.com
Inoa Kimia | 4-(3-Chloropropyl)morpholine |
Nā huaʻōlelo like | N-(3-Chloropropyl)morpholine;3-Morpholinopropyl Chloride;1-Chloro-3-(Morpholin-4-yl)propane;1-Chloro-3-Morpholinopropane;3-(Morpholin-4-yl)propyl Chloride;3-Chloro-1-(Morpholin-4-yl)propane;ʻO ka haumia ʻo Gefitinib VI |
Kūlana Kūʻai | Ma ke Kahua, Hana Hana Kūʻai |
Helu CAS | 7357-67-7 |
ʻĀpana Molekala | C7H14ClNO |
Kaumaha Molecular | 163.65 g/mol |
Lae paila | 115 ℃/25mmHg(māmā) |
Lae Flash | 91 ℃ |
Pilikino | Paʻi Lewa, Paʻa Wela |
COA & MSDS | Loaʻa |
Laʻana | Loaʻa |
Ke kumu | Shanghai, Kina |
Brand | Kemika Ruifu |
Nā mea | Nā Kūlana Nānā | Nā hualoaʻa |
Ka nana aku | ʻAʻole waihoʻoluʻu i ka ʻulaʻula Melemele Māmā wai | Hoʻokō |
Maʻemaʻe / Kaʻina Hanana | >98.0% (GC) | 99.35% |
Wai na Karl Fischer | <0.50% | 0.26% |
ʻO ka haumia hoʻokahi kiʻekiʻe | <0.50% | <0.50% |
Huina paumaele | <2.00% | 0.65% |
Hōʻike Hōʻikeʻike N20/D | 1.4705~1.4765 | Hoʻokō |
ʻOi (20 ℃) | 1.077~1.081 | Hoʻokō |
1 H NMR Spectrum | Kūlike me ka Hoʻolālā | Hoʻokō |
Ka hopena | Ua hoʻāʻo ʻia ka huahana a hoʻokō me nā kikoʻī i hāʻawi ʻia | |
Palapala noi | Kūwaena o Gefitinib (CAS: 184475-35-2) |
Pūʻolo:Fluorinated Bottle, 25kg/Drum, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E hoʻopaʻa paʻa i ka pahu a mālama i loko o kahi hale kūʻai maloʻo a me ka makani maikaʻi mai nā mea like ʻole.E pale i ka malamalama a me ka wai.
Hoʻouna:Hāʻawi i ka honua ma ka lewa, e FedEx / DHL Express.Hāʻawi wikiwiki a hilinaʻi hoʻi.
Pehea e kūʻai ai?E ʻoluʻolu e kelepona maiDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 mau makahiki ʻike?Loaʻa iā mākou ma mua o 15 mau makahiki o ka ʻike i ka hana ʻana a me ka hoʻokuʻu ʻana aku i kahi ākea ākea o nā intermediates pharmaceutical kiʻekiʻe a i ʻole nā kemika maikaʻi.
Mākeke Nui?E kūʻai aku i ka mākeke kūloko, ʻAmelika ʻĀkau, ʻEulopa, India, Korea, Iapana, Australia, etc.
Nā pono?ʻO ke kūlana kiʻekiʻe, ke kumukūʻai kūpono, nā lawelawe ʻoihana a me ke kākoʻo ʻenehana, ka lawe wikiwiki ʻana.
ʻAno maikaʻiHōʻoiaʻiʻo?Pūnaehana hoʻomalu maikaʻi koʻikoʻi.ʻO nā lako ʻoihana no ka nānā ʻana ʻo NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Nā laʻana?Hāʻawi ka hapa nui o nā huahana i nā laʻana manuahi no ka loiloi maikaʻi, pono e uku ʻia ke kumukūʻai e nā mea kūʻai aku.
Hooia Hale Hana?Welina mai ka loiloi hale hana.E ʻoluʻolu e hoʻopaʻa manawa ma mua.
MOQ?ʻAʻohe MOQ.ʻAe ʻia ke kauoha liʻiliʻi.
Manawa Hoʻouna? Inā i loko o ka waihona, ʻekolu lā hoʻouna ʻia.
Kaʻahele?Ma ka Express (FedEx, DHL), ma ka Air, ma ke Kai.
Nā palapala?Ma hope o ka lawelawe kūʻai: COA, MOA, ROS, MSDS, etc.
Hoʻohui Kuʻuna?Hiki ke hāʻawi i nā lawelawe synthesis maʻamau e kūpono i kāu mau pono noiʻi.
Kūkākūkā uku?E hoʻouna mua ʻia ka invoice Proforma ma hope o ka hōʻoia ʻana o ke kauoha, hoʻopili ʻia kā mākou ʻike panakō.Uku e T/T (Telex Transfer), PayPal, Western Union, etc.
Nā Code Risk
36/37/38 - E hoʻonāukiuki i ka maka, ka hanu a me ka ʻili.
Ka wehewehe palekana
S26 - Inā pili me nā maka, e holoi koke me ka wai nui a e ʻimi i ka ʻōlelo aʻo kino.
S36/37/39 - E hoʻohana i nā lole pale kūpono, nā mīkina lima a me ka pale maka/maka.
RTECS QE0488000
PILI PILI
ʻO 4-(3-Chloropropyl)morpholine (CAS: 7357-67-7) ka mea waena o Gefitinib (CAS: 184475-35-2).ʻO Gefitinib, he lāʻau lapaʻau i hoʻohana ʻia no kekahi mau maʻi maʻi maʻi maʻi ʻē aʻe, i ʻike ʻia ʻo Iressa, kahi mea hoʻopaneʻe tyrosine kinase inhibitor koho epidermal growth factor (EGFR), no ka mālama ʻana i ka lāʻau lapaʻau mua a i ʻole ka metastatic non-chemical treatment a i ʻole kūpono ʻole. ka maʻi ʻaʻai ʻana o ka maʻi ʻōpū liʻiliʻi liʻiliʻi (NSCLC).ʻO Gefitinib kahi lāʻau lapaʻau anti-tumor i hoʻolālā ʻia e AstraZeneca ma United Kingdom.ʻO ia ka lāʻau lapaʻau mua i hoʻopaʻa ʻia no ka mālama ʻana i ka maʻi maʻi maʻi ʻaʻole liʻiliʻi.